Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2007 1
2008 6
2009 2
2010 5
2011 5
2012 4
2013 3
2014 7
2015 12
2016 9
2017 7
2018 4
2019 5
2020 17
2021 13
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Regulation of Osteoclast Differentiation by Cytokine Networks.
Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Amarasekara DS, et al. Among authors: lee n. Immune Netw. 2018 Feb 7;18(1):e8. doi: 10.4110/in.2018.18.e8. eCollection 2018 Feb. Immune Netw. 2018. PMID: 29503739 Free PMC article. Review.
A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.
Jeong SH, Yeon SE, Kim SY, Kwon TG, Jeon SS, Choi YD, Kwon D, Chung BH, Hong SH, Kim BH, Lee HJ, Shin SJ, Choi WS, Park SW, Kang TW, Yun SJ, Cho JS, Choi SM, Lee NR, Kwak C. Jeong SH, et al. Investig Clin Urol. 2023 Sep;64(5):466-473. doi: 10.4111/icu.20230128. Investig Clin Urol. 2023. PMID: 37668202 Free PMC article.
108 results